Showing results (331-340 of 542) with videos related to
Sort By:
Pageof 55
Neurodegenerative Disease Management|February 18, 2022
Effects of an low carbohydrate/healthy fat/ketogenic diet on biomarkers of health and symptoms, anxiety and depression in Parkinson's disease: a pilot studyMelanie M Tidman, Dawn White, Timothy WhiteNeurodegenerative Disease Management|April 21, 2022
Healthcare resource utilization and costs for extended interval dosing of natalizumab in multiple sclerosisMarcello Moccia, Ilaria Loperto, Laura Santoni, et al.Neurodegenerative Disease Management|June 27, 2018
Phase III SUNBEAM and RADIANCE PART B trials for Ozanimod in relapsing multiple sclerosis demonstrate superiority versus interferon-β-1a (Avonex®) in reducing annualized relapse rates and MRI brain lesionsVolker KoscielnyNeurodegenerative Disease Management|May 23, 2019
Lifestyle-based modifiable risk factors in multiple sclerosis: review of experimental and clinical findingsDejan Jakimovski, Yi Guan, Murali Ramanathan, et al.Neurodegenerative Disease Management|May 24, 2019
Update on current and emerging therapies for dystoniaKarlo J Lizarraga, Duha Al-Shorafat, Susan FoxNeurodegenerative Disease Management|April 19, 2019
Personality and the risk factors for developing behavioral and psychological symptoms of dementia: a narrative reviewJuan J Young, Silpa Balachandran, Garima Garg, et al.Neurodegenerative Disease Management|September 19, 2018
Mini-Mental State Examination: diagnostic test accuracy study in primary care referralsAndrew J LarnerNeurodegenerative Disease Management|September 19, 2018
Speech disorders in Parkinson's disease: pathophysiology, medical management and surgical approachesKhashayar Dashtipour, Ali Tafreshi, Jessica Lee, et al.Neurodegenerative Disease Management|June 24, 2017
Visual dot interaction with short-term memoryFaustin Armel Etindele SossoNeurodegenerative Disease Management|September 14, 2012
OPTIMIZING DIAGNOSIS AND MANANGEMENT IN MILD-TO-MODERATE ALZHEIMER'S DISEASEJames E GalvinPageof 55